Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2024-516033-12-00Phase 3Authorised
Phase 3, randomised, double-blind trial of Placebo-COD Research Private Ltd in Atrial fibrillation (AFib) (2 arms), sponsored by University Hospital Basel. Planned start Jun 2026; status: authorised.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2024-516033-12-00.